eISSN: 2081-2833
ISSN: 2081-0016
Medycyna Paliatywna/Palliative Medicine
Current issue Archive About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors
4/2016
vol. 8
 
Share:
Share:
more
 
 
abstract:

Short-acting opioids validity in the treatment of neoplastic patients with long-term survival in the background of addiction and quality of life. Case report

Katarzyna Malinowska
,
Kamil Lachowicz
,
Aleksandra Ciałkowska-Rysz

Medycyna Paliatywna 2016; 8(4): 192–201
Online publish date: 2017/03/07
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Considering planning of symptomatic treatment, in addition to medical aspects, we should assess the patient’s attitude to his own disease, the level of doctor-patient communication, the burden in history of addictive disease, quality of life. The study included a patient with a diagnosed diffuse large B-cell lymphoma (DLBCL) with metastasis to bones and spine, falling under an outpatient palliative medicine because of the persistent pain. The aim of this study was to determine whether in the described case of the patient treated with intranasal administered, short-acting opioid is justified to further continue the treatment plan, or to change the therapeutic concept, dictated by fear of developing an addiction to the drug, due to non-compliance with the recommendations by the patient.
keywords:

short-acting opioid, quality of life, addiction

Quick links
© 2019 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe